Advertisement
Advertisement
U.S. markets open in 5 hours 55 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Cryo-Cell International, Inc. (CCEL)

NYSE American - NYSE American Delayed Price. Currency in USD
4.8900+0.0500 (+1.03%)
At close: 12:46PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close4.8400
Open5.0000
Bid0.0000 x 800
Ask0.0000 x 800
Day's Range4.8900 - 5.0000
52 Week Range4.6800 - 14.0000
Volume2,534
Avg. Volume8,703
Market Cap41.659M
Beta (5Y Monthly)0.42
PE Ratio (TTM)32.60
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateSep 01, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-16% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CCEL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Cryo-Cell International, Inc.
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement